• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 03/01/2023
Event Type  Injury  
Event Description
Initially the jada was working and controlling the bleeding, but then it clotted off [device occlusion].Did a d&c on the pateint but the patient continued to bleed [device ineffective].Removed the jada, did another manual sweep of the patient, and then tried to replace the jada [device use error].Case narrative: this initial spontaneous report originating from the united states, was received from a physician and nurse via clinical account specialist referring to a 22-year-old female patient.The patient¿s current conditions included uterine atony.The patient¿s historical conditions included singleton pregnancy, bleeding, cesarean, fetal demise, and blood products transfusion (unknown volume).The patient¿s concomitant medications were not reported.This report concerned 1 patient and 1 device.On an unknown date in (b)(6) 2023 (reported as 1-2 weeks ago), the patient was started on vacuum-induced hemorrhage control system (jada system) (lot# and expiry date were not reported) (came with blue seal valve, kit and green carton) vaginally as directed by the health care professional (hcp) for postpartum hemorrhage (postpartum haemorrhage).Initially the vacuum-induced hemorrhage control system (jada system) was worked and controlled the bleeding, but then it clotted off (also reported as initially it worked and the uterine tone was slightly improved but then it clotted off) (device occlusion).The physician removed the vacuum-induced hemorrhage control system (jada system) and did another manual sweep of the patient, and then tried to replace the vacuum-induced hemorrhage control system (jada system) but it immediately clogged off again (device use error).Then the physician did dilation and curettage (d&c) on the patient, but the patient continued to bleed (device ineffective).The device was operated by fellow, maternal fetal medicine and it may be first time for the operator.The physician tried placing another vacuum-induced hemorrhage control system (jada system), but it also clotted off (also reported that the second one was used as the first one clotted off and was no longer sterile) (captured in oars# (b)(4)).The patient then underwent hysterectomy and bleeding was controlled.The patient sought medical attention.Therapy with vacuum-induced hemorrhage control system (jada system) was discontinued.The availability of the vacuum-induced hemorrhage control system (jada system) for evaluation was unknown.Upon internal review, the event of device occlusion and device ineffective was determined to be serious: required intervention.This is one of the two reports received from the same reporter.Medical device reporting criteria: serious injury.Fda code: (health effects - health impact per annex f): 4648 insufficient information (there is not yet enough information available to classify the health impact.).Fda code: (health effects - health impact per annex f): 4624 surgical intervention (one or more surgical procedures was required, or an existing procedure changed.).
 
Manufacturer Narrative
Based on the information we have received, there is no indication that the device malfunctioned.The device is assembled according to specifications.In process and finished product testing are performed and approved prior to release.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer (Section G)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer Contact
30 hudson street
jersey city, NJ 07302
MDR Report Key16613007
MDR Text Key311971071
Report Number3002806821-2023-00030
Device Sequence Number1
Product Code OQY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
510K K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/24/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age22 YR
Patient SexFemale
-
-